{"id":83405,"topic":"peptides","source":"Bloomberg Law News","title":"FDA Advisers Back Looser Rules For Six Peptides, Reject One (1) - Bloomberg Law News","url":"https://news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing","url_hash":"c1a1914a3c4dd0e414f11ff863de8d9821cdd48a","author":"","summary":"FDA Advisers Back Looser Rules For Six Peptides, Reject One (1) Bloomberg Law News","content":"An FDA advisory committee advanced recommendations for six popular peptides to be legally compounded and sold by pharmacies, rejecting only one substance for looser manufacturing restrictions championed by US Health Secretary Robert F. Kennedy Jr.\nThe agencyâs outside advisers sitting on the Pharmacy Compounding Advisory Committee on Friday only declined to reclassify the peptide Emideltide as a substance that pharmacies would be allowed to legally market. The unapproved product is being evaluated for its use for opioid withdrawal and insomnia.\nHowever, in votes Thursday and Friday, the majority of the committee agreed to recommend the unapproved peptides for compounding: Epitalon ...\nLearn more about Bloomberg Law or Log In to keep reading:\nSee Breaking News in Context\nBloomberg Law provides trusted coverage of current events enhanced with legal analysis.\nAlready a subscriber?\nLog in to keep reading or access research tools and resources.","image_url":"https://news-api.bloomberglaw.com/v1/resize-image?url=https%3A%2F%2Fbloomberg-bna-brightspot.s3.us-east-1.amazonaws.com%2F7c%2Fe8%2F3c786fdc4ccd9594280702d26696%2F364235090.jpg&width=1200&height=600&fit=cover&crop=3994x1539%2B3%2B1128","lang":"en","published_at":"2026-07-24T07:00:00+00:00","fetched_at":"2026-09-16T02:15:11+00:00","status":"read","starred":0,"extract_state":"ok","summary_auto":"An FDA advisory committee advanced recommendations for six popular peptides to be legally compounded and sold by pharmacies, rejecting only one substance for looser manufacturing restrictions championed by US Health Secretary Robert F. The agencyâs outside advisers sitting on the Pharmacy Compounding Advisory Committee on Friday only declined to reclassify the peptide Emideltide as a substance that pharmacies would be allowed to legally market.","cluster_id":null,"extract_retries":0,"extract_error":null,"contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 953 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":953,"summary_length":448,"usable_text_length":953,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":953,"summary_length":448}},"news_item":{"id":83405,"canonical_url":"https://news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing","source_url":"https://news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing","title":"FDA Advisers Back Looser Rules For Six Peptides, Reject One (1) - Bloomberg Law News","source_name":"Bloomberg Law News","author":null,"published_at":"2026-07-24T07:00:00+00:00","locale":"en","topic":"peptides","tags":[],"rss_summary":"FDA Advisers Back Looser Rules For Six Peptides, Reject One (1) Bloomberg Law News","full_text":"An FDA advisory committee advanced recommendations for six popular peptides to be legally compounded and sold by pharmacies, rejecting only one substance for looser manufacturing restrictions championed by US Health Secretary Robert F. Kennedy Jr.\nThe agencyâs outside advisers sitting on the Pharmacy Compounding Advisory Committee on Friday only declined to reclassify the peptide Emideltide as a substance that pharmacies would be allowed to legally market. The unapproved product is being evaluated for its use for opioid withdrawal and insomnia.\nHowever, in votes Thursday and Friday, the majority of the committee agreed to recommend the unapproved peptides for compounding: Epitalon ...\nLearn more about Bloomberg Law or Log In to keep reading:\nSee Breaking News in Context\nBloomberg Law provides trusted coverage of current events enhanced with legal analysis.\nAlready a subscriber?\nLog in to keep reading or access research tools and resources.","excerpt":"An FDA advisory committee advanced recommendations for six popular peptides to be legally compounded and sold by pharmacies, rejecting only one substance for looser manufacturing restrictions championed by US Health Secretary Robert F. The agencyâs outside advisers sitting on the Pharmacy Compounding Advisory Committee on Friday only declined to reclassify the peptide Emideltide as a substance that pharmacies would be allowed to legally market.","extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 953 characters.","diagnostics_url":"/api/diagnose?url=https%3A//news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 953 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":953,"summary_length":448,"usable_text_length":953,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":953,"summary_length":448}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"FDA Advisers Back Looser Rules For Six Peptides, Reject One (1) - Bloomberg Law News","url":"https://news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing","summary":"An FDA advisory committee advanced recommendations for six popular peptides to be legally compounded and sold by pharmacies, rejecting only one substance for looser manufacturing restrictions championed by US Health Secretary Robert F. The agencyâs outside advisers sitting on the Pharmacy Compounding Advisory Committee on Friday only declined to reclassify the peptide Emideltide as a substance that pharmacies would be allowed to legally market.","source":"Bloomberg Law News","date":"2026-07-24T07:00:00+00:00","content":"An FDA advisory committee advanced recommendations for six popular peptides to be legally compounded and sold by pharmacies, rejecting only one substance for looser manufacturing restrictions championed by US Health Secretary Robert F. Kennedy Jr.\nThe agencyâs outside advisers sitting on the Pharmacy Compounding Advisory Committee on Friday only declined to reclassify the peptide Emideltide as a substance that pharmacies would be allowed to legally market. The unapproved product is being evaluated for its use for opioid withdrawal and insomnia.\nHowever, in votes Thursday and Friday, the majority of the committee agreed to recommend the unapproved peptides for compounding: Epitalon ...\nLearn more about Bloomberg Law or Log In to keep reading:\nSee Breaking News in Context\nBloomberg Law provides trusted coverage of current events enhanced with legal analysis.\nAlready a subscriber?\nLog in to keep reading or access research tools and resources.","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 953 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 953 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":953,"summary_length":448,"usable_text_length":953,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":953,"summary_length":448}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/83405","export_markdown":"/api/items/83405/export?format=markdown","export_json":"/api/items/83405/export?format=json","diagnose":"/api/diagnose?url=https%3A//news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing"},"formats":{"full":{"id":83405,"title":"FDA Advisers Back Looser Rules For Six Peptides, Reject One (1) - Bloomberg Law News","url":"https://news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing","source":"Bloomberg Law News","author":null,"published_at":"2026-07-24T07:00:00+00:00","locale":"en","topic":"peptides","tags":[],"excerpt":"An FDA advisory committee advanced recommendations for six popular peptides to be legally compounded and sold by pharmacies, rejecting only one substance for looser manufacturing restrictions championed by US Health Secretary Robert F. The agencyâs outside advisers sitting on the Pharmacy Compounding Advisory Committee on Friday only declined to reclassify the peptide Emideltide as a substance that pharmacies would be allowed to legally market.","full_text":"An FDA advisory committee advanced recommendations for six popular peptides to be legally compounded and sold by pharmacies, rejecting only one substance for looser manufacturing restrictions championed by US Health Secretary Robert F. Kennedy Jr.\nThe agencyâs outside advisers sitting on the Pharmacy Compounding Advisory Committee on Friday only declined to reclassify the peptide Emideltide as a substance that pharmacies would be allowed to legally market. The unapproved product is being evaluated for its use for opioid withdrawal and insomnia.\nHowever, in votes Thursday and Friday, the majority of the committee agreed to recommend the unapproved peptides for compounding: Epitalon ...\nLearn more about Bloomberg Law or Log In to keep reading:\nSee Breaking News in Context\nBloomberg Law provides trusted coverage of current events enhanced with legal analysis.\nAlready a subscriber?\nLog in to keep reading or access research tools and resources.","reading_time_min":1,"extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 953 characters.","diagnostics_url":"/api/diagnose?url=https%3A//news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 953 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":953,"summary_length":448,"usable_text_length":953,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":953,"summary_length":448}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 953 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":953,"summary_length":448,"usable_text_length":953,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":953,"summary_length":448}},"actions":{"read":"/item/83405","export_markdown":"/api/items/83405/export?format=markdown","export_json":"/api/items/83405/export?format=json","diagnose":"/api/diagnose?url=https%3A//news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing"}},"digest":{"id":83405,"title":"FDA Advisers Back Looser Rules For Six Peptides, Reject One (1) - Bloomberg Law News","url":"https://news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing","source":"Bloomberg Law News","topic":"peptides","published_at":"2026-07-24T07:00:00+00:00","excerpt":"An FDA advisory committee advanced recommendations for six popular peptides to be legally compounded and sold by pharmacies, rejecting only one substance for looser manufacturing restrictions championed by US Health Secretary Robert F. The agencyâs outside advisers sitting on…","quality_bucket":"high","quality_reason":"High confidence: full text extraction produced 953 characters.","reading_time_min":1,"cluster_id":null},"card":{"display_title":"FDA Advisers Back Looser Rules For Six Peptides, Reject One (1) - Bloomberg Law News","subtitle":"Bloomberg Law News · 2026-07-24","summary":"An FDA advisory committee advanced recommendations for six popular peptides to be legally compounded and sold by pharmacies, rejecting only one substance for looser manufacturing restrictions championed by US Health…","badges":["quality:high"],"links":{"read":"/item/83405","original":"https://news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing","diagnose":"/api/diagnose?url=https%3A//news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing"},"quality_warning":null},"export":{"title":"FDA Advisers Back Looser Rules For Six Peptides, Reject One (1) - Bloomberg Law News","url":"https://news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing","summary":"An FDA advisory committee advanced recommendations for six popular peptides to be legally compounded and sold by pharmacies, rejecting only one substance for looser manufacturing restrictions championed by US Health Secretary Robert F. The agencyâs outside advisers sitting on the Pharmacy Compounding Advisory Committee on Friday only declined to reclassify the peptide Emideltide as a substance that pharmacies would be allowed to legally market.","source":"Bloomberg Law News","date":"2026-07-24T07:00:00+00:00","content":"An FDA advisory committee advanced recommendations for six popular peptides to be legally compounded and sold by pharmacies, rejecting only one substance for looser manufacturing restrictions championed by US Health Secretary Robert F. Kennedy Jr.\nThe agencyâs outside advisers sitting on the Pharmacy Compounding Advisory Committee on Friday only declined to reclassify the peptide Emideltide as a substance that pharmacies would be allowed to legally market. The unapproved product is being evaluated for its use for opioid withdrawal and insomnia.\nHowever, in votes Thursday and Friday, the majority of the committee agreed to recommend the unapproved peptides for compounding: Epitalon ...\nLearn more about Bloomberg Law or Log In to keep reading:\nSee Breaking News in Context\nBloomberg Law provides trusted coverage of current events enhanced with legal analysis.\nAlready a subscriber?\nLog in to keep reading or access research tools and resources.","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearing","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 953 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 953 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":953,"summary_length":448,"usable_text_length":953,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":953,"summary_length":448}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}